—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Merck & Company Inc (MRK) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for MRK, from the same nightly bakes the boards use. Research diary readings, not advice.

Mentioned on Closelooknet 1 piece · newest: Midday 10, “A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000” (2026-08-21)

Mentioned on Closelooknet

Where MRK appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.80 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How MRK has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.80 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Merck & Company Inc moved 0.80% on average · correlation 0.25 · higher than 77% of US names
  • Beta, last 3 months 1.63 more rate-sensitive lately than over the year
  • On the 10 worst bond days −1.05% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −0.07% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Drug Manufacturers - General · US · 8 names with week and year-to-date

Peer group

Drug Manufacturers - General · US

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against MRK on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Merck & Company Inc

MRK in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Merck is a pharmaceutical and healthcare company that sells prescription medicines, vaccines and animal-health products worldwide. Its human-health portfolio includes the oncology drug Keytruda, vaccines such as Gardasil and ProQuad, and treatments across cardiology, infectious disease and diabetes. It also runs a separate animal-health business selling livestock and companion-animal medicines. Merck is based in Rahway, New Jersey, and has been listed since 1978.
Where it sits in the stack
Merck sits outside our AI build-out index; it belongs to the healthcare sleeve of our universe as a pharmaceutical manufacturer rather than a supplier to the compute stack.
Who it is priced against
Its industry classification places it with other large drug manufacturers; the comparison the market draws most often is with Pfizer.
Why Closelooknet tracks it
Merck is a Dow Jones Industrial Average constituent; it carries no Closelooknet score yet. The diary has quoted it once, in a Midday 10 note listing it among health-care names making new 52-week highs.
What the diary watches
Whether Keytruda's contribution to group revenue and the pace of new drug and vaccine approvals keep the earnings base broadening beyond that single product.

Merck & Company Inc (MRK) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: MRK news on the tape · index compare · sector dispersion · scanner.

The Street on this name 9 analyst actions on the wire · latest: price target by Guggenheim, 2026-09-08

The Street on this name

Analyst actions and the latest print for MRK from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Guggenheim — target 170 Target set to $170 (+13.1% to spot) 2026-09-08
  • Price target Wells Fargo — target 170 from 150 Target raised to $170 from $150 (+11.6% to spot) 2026-09-04
  • Price target Argus — target 170 from 145 Target raised to $170 from $145 (+10.7% to spot) 2026-08-25

9 actions on the analyst wire since 2026-08-13: 9 target changes. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 2.29%, quarterly · last 0.85 USD on 2026-09-15

Dividends and capital return

What MRK pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 3.40 USD per share · a 2.29% yield on the 2026-09-25 close 4 distributions, paid quarterly 2026-09-25
  • Change on the year +4.9% against the prior twelve months prior twelve months 3.24 USD per share
  • Last distribution 0.85 USD per share as the price series records it, within days of the ex-date 2026-09-15
  • By calendar year 2023: 0.77 USD (partial) · 2024: 3.12 USD · 2025: 3.28 USD · 2026: 2.55 USD to date first distribution recorded in the three-year window: 2023-12-14

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Merck & Company Inc (MRK)?

Merck & Company Inc trades as MRK on the US exchange (US) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is MRK in a Closelooknet index?

Not currently — Merck & Company Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does MRK trade against its moving averages?

Uptrend stack intact: Trades +6% vs the 50-day and +22.6% vs the 200-day average, 5.2% below the 52-week high and +94.8% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Merck & Company Inc trade when bond yields rise?

Over the past year Merck & Company Inc had a beta of 0.80 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 77% of US names. On the 10 sessions in which long bonds fell most it moved −1.05% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

Where has Closelooknet written about Merck & Company Inc?

Merck & Company Inc appears in 1 Closelooknet piece, most recently Midday 10: A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000 (2026-08-21). What Closelooknet said most recently: Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG… (Midday 10, 2026-08-21). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

What does Merck & Company Inc do?

Merck is a pharmaceutical and healthcare company that sells prescription medicines, vaccines and animal-health products worldwide. Its human-health portfolio includes the oncology drug Keytruda, vaccines such as Gardasil and ProQuad, and treatments across cardiology, infectious disease and diabetes. It also runs a separate animal-health business selling livestock and companion-animal medicines. Its industry classification places it with other large drug manufacturers; the comparison the market draws most often is with Pfizer.

Where does Merck & Company Inc sit in the AI build-out?

Merck sits outside our AI build-out index; it belongs to the healthcare sleeve of our universe as a pharmaceutical manufacturer rather than a supplier to the compute stack. Merck is a Dow Jones Industrial Average constituent; it carries no Closelooknet score yet. The diary has quoted it once, in a Midday 10 note listing it among health-care names making new 52-week highs.

Does Merck & Company Inc pay a dividend?

Merck & Company Inc has paid 3.40 USD per share over the last twelve months, paid quarterly, a trailing yield of 2.29% on the 2026-09-25 close; the last distribution recorded in the price series was 0.85 USD on 2026-09-15. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Merck & Company Inc recently?

The most recent analyst action on Merck & Company Inc on the Closelooknet wire is a price target by Guggenheim on 2026-09-08 (target 170). 9 actions on the analyst wire since 2026-08-13: 9 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for MRK, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.